PubRank

D Campana

Author PubWeight™ 113.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 2004 3.59
2 Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998 3.07
3 Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000 2.92
4 Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2009 2.24
5 Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996 2.10
6 Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 2000 1.94
7 Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia 2004 1.87
8 Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 2004 1.65
9 An essential role for BLNK in human B cell development. Science 1999 1.64
10 A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res 1985 1.61
11 Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol 2004 1.57
12 Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998 1.55
13 PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol 1995 1.51
14 Childhood acute lymphoblastic leukaemia--current status and future perspectives. Lancet Oncol 2001 1.48
15 Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992 1.42
16 Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol 1985 1.41
17 Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 2005 1.41
18 PAMELA measurements of cosmic-ray proton and helium spectra. Science 2011 1.39
19 "Cytoplasmic" expression of nuclear antigens. Leukemia 1989 1.38
20 IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma. Blood 1998 1.33
21 Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial. Leukemia 2009 1.33
22 Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method. Cancer Gene Ther 2009 1.32
23 Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest 1999 1.32
24 Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest 1985 1.30
25 Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa. Immunology 1989 1.24
26 Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood 1996 1.24
27 Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993 1.20
28 Natural killer cell engineering for cellular therapy of cancer. Tissue Antigens 2011 1.18
29 Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 1994 1.14
30 Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 1996 1.14
31 Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 1996 1.14
32 X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol Rev 1994 1.09
33 ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia 2011 1.08
34 Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 1981 1.08
35 The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 1987 1.07
36 Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia 2009 1.07
37 An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature 2009 1.07
38 Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest 1994 1.05
39 Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood 2001 1.05
40 CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase. J Immunol 1996 1.05
41 Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Dig Liver Dis 2007 1.05
42 Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma. Hum Gene Ther 1998 1.04
43 T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol 1986 1.04
44 Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. Leukemia 2012 1.03
45 Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 1994 1.03
46 Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 1995 1.01
47 Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999 0.99
48 Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia. Blood 1986 0.99
49 The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia 1989 0.97
50 Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 1997 0.97
51 Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 2001 0.96
52 Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells. Blood 1998 0.94
53 Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest 2011 0.94
54 Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia 1994 0.92
55 Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study. Leukemia 2011 0.92
56 New measurement of the antiproton-to-proton flux ratio up to 100 GeV in the cosmic radiation. Phys Rev Lett 2009 0.92
57 Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central America. Leukemia 2005 0.91
58 Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 1993 0.90
59 Molecular interactions between human B-cell progenitors and the bone marrow microenvironment. Exp Cell Res 1996 0.89
60 Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res 1984 0.88
61 CD38 ligation inhibits normal and leukemic myelopoiesis. Blood 2000 0.88
62 Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells. Blood 2001 0.87
63 In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 1998 0.87
64 Fas activates NF-kappaB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-alpha. Cell Death Differ 1997 0.86
65 Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 1996 0.86
66 CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood 1996 0.86
67 Kinetics of T lymphocyte development. Curr Top Pathol 1989 0.86
68 Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1999 0.86
69 Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells. Blood 1998 0.85
70 Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study. Leukemia 2008 0.85
71 CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. J Immunol 1999 0.85
72 CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. J Immunol 1997 0.85
73 Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia 2009 0.84
74 Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia 2007 0.83
75 Human leukocyte function-associated antigens on lympho-hemopoietic precursor cells. Eur J Immunol 1986 0.83
76 New definition of remission in childhood acute lymphoblastic leukemia. Leukemia 2000 0.83
77 Pancreatic involvement in systemic sarcoidosis. A case report. Dig Liver Dis 2004 0.82
78 N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 1993 0.82
79 Simple methods for the rapid exchange of flow cytometric data between remote centers. Leukemia 2000 0.81
80 Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Clin Exp Immunol 1984 0.81
81 Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia. Leukemia 2004 0.81
82 Autoimmune pancreatitis: the classification puzzle. Adv Med Sci 2007 0.80
83 Immune-complexes and antiplatelet antibodies in idiopathic thrombocytopenic purpura. Haematologica 1983 0.80
84 The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis. Leukemia 2002 0.80
85 Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells. Leukemia 1995 0.79
86 A possible pathogenetic role of cationic proteins (CP) released by stored granulocytes in the development of pulmonary infiltrates after granulocyte transfusions. Scand J Haematol 1985 0.79
87 Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines? J Biol Regul Homeost Agents 2003 0.78
88 Signals mediated by FcgammaRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells. Leukemia 2002 0.78
89 Genetic modification of T cells for cancer therapy. J Biol Regul Homeost Agents 2004 0.78
90 PAMELA results on the cosmic-ray antiproton flux from 60 MeV to 180 GeV in kinetic energy. Phys Rev Lett 2010 0.77
91 Cosmic-ray electron flux measured by the PAMELA experiment between 1 and 625 GeV. Phys Rev Lett 2011 0.77
92 Toward a clinically useful classification of the acute leukemias. Leukemia 1995 0.77
93 Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. Leukemia 1987 0.77
94 The origin of B-chronic lymphocytic leukaemia (B-CLL) and its relationship to hairy cell leukaemia (HCL). Adv Exp Med Biol 1985 0.77
95 Multiple chromosome abnormalities in a drug resistant TdT positive B-cell leukemia. Leuk Res 1987 0.77
96 Characterization of normal and regenerating bone marrow cells with a panel of monoclonal antibodies. Scand J Haematol 1986 0.76
97 Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects. Q J Med 1989 0.76
98 Cosmic-ray positron energy spectrum measured by PAMELA. Phys Rev Lett 2013 0.76
99 Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1996 0.76
100 Lubrication during colonoscopy: a forgotten factor. Dig Liver Dis 2005 0.75
101 A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. Endocrine 2002 0.75
102 Sedation during colonoscopy and the benefits of lubrication. Aliment Pharmacol Ther 2007 0.75
103 Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002. Ann Oncol 2013 0.75
104 Phenotypic changes and proliferative activity of human gamma delta T cell receptor-bearing cells upon activation. Clin Exp Immunol 1991 0.75
105 The role of somatostatin analogs in the management of carcinoid tumors. J Endocrinol Invest 2003 0.75
106 Immunophenotyping in haematological diagnosis. Baillieres Clin Haematol 1990 0.75
107 Recombinant interleukin 2 and anti-Tac influence the growth of enriched multipotent hemopoietic progenitors: proposed hypotheses for different responses in early and late progenitors. Leuk Res 1988 0.75
108 B-chronic lymphocytic leukaemia patients with stable benign disease show a distinctive membrane phenotype. Br J Haematol 1984 0.75
109 Development of B cell subpopulations in humans and its relevance to malignancy. Haematol Blood Transfus 1985 0.75
110 Minimal residual disease in hematologic malignancies. Rev Invest Clin 1994 0.75
111 Rapid down-regulation of protein kinase C and membrane association in phorbol ester-treated leukemia cells. FEBS Lett 1985 0.75
112 Leukaemia and lymphoma treatment with autologous bone marrow transplantation: preclinical studies. Cancer Detect Prev 1988 0.75
113 Relevance of monoclonal antibodies in the diagnosis of unusual T-cell acute lymphoblastic leukaemia. Scand J Haematol 1983 0.75
114 Basis for treatment of functioning neuroendocrine tumours. Dig Liver Dis 2004 0.75
115 Atypical Wiskott-Aldrich syndrome in a girl. Blood 1992 0.75
116 Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies. Leukemia 1988 0.75
117 Immune-complexes (IC) in idiopathic neutropenia. Scand J Haematol 1981 0.75
118 Karyotype and T-cell receptor expression in T-lineage acute lymphoblastic leukemia. Genes Chromosomes Cancer 1992 0.75
119 Evaluation of patient-reported outcome in subjects treated medically for acute pancreatitis: a follow-up study. Pancreatology 2009 0.75
120 Correlation of immunophenotype with rearrangement of T cell antigen receptor beta and gamma genes in acute lymphoblastic leukemia of adults. Leukemia 1988 0.75